Specific elimination of PTEN in mouse hematopoietic cells leads to the development of acute myeloid leukemia or acute lymphoid leukemia, highlighting its critical role in activating the PI3K/Akt pathway and, consequently, in hematopoietic development and leukemogenesis [11,12]. The gene discussed is PTEN; the disease is acute lymphoblastic leukemia.